Literature DB >> 11778150

Colonic fermentation as affected by antibiotics and acidic pH: Application of an in vitro model.

A Bender1, G Breves, J Stein, S Leonhard-Marek, B Schröder, C Winckler.   

Abstract

Antimicrobial substances such as vancomycin or metronidazole suppress normal gut flora, thereby preventing physiological fermentation of colonic substrates that may promote mucosal inflammation. This study was designed to establish an in vitro model of microbial metabolism in the colon under control and disturbed conditions (acidic pH) to investigate specific effects of vancomycin and metronidazole on the production of short chain fatty acids (SCFA), which play a pivotal role in maintaining homeostasis in the colon. The experiments were carried out with the colon simulation technique (Cositec) representing an in vitro model for the semi-continuous incubation of defined colon contents. Inocula and fermentable substrates were sampled from cecal contents of fistulated pigs. Disturbed microbial metabolism was generated by reduction of pH in the fermentation vessels from 6.7 to 5.8 and 5.1. In general, application of either vancomycin or metronidazole resulted in a significant decrease of SCFA production rates indicating substantial disturbance of the homeostasis of microbial metabolism. With low doses of vancomycin acetate and butyrate production rates were reduced and with high doses of the antibiotic propionate production was inhibited to a greater extent. Treatment with metronidazole inhibited butyrate production almost completely. Similarly, low pH caused a reduction in total SCFA production, which was mainly due to respective decrease of acetate synthesis. Metronidazole effects were not consistently changed at low pH. The Cositec system provides an excellent facility to test the effects of different antibiotics under defined conditions. In this study, both vancomycin and metronidazole affected microbial metabolism to a considerable extent. Both substances may thus be responsible for disturbances of colon function in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11778150     DOI: 10.1055/s-2001-18537

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  7 in total

1.  Robustness of the non-neuronal cholinergic system in rat large intestine against luminal challenges.

Authors:  Sandra Bader; Stefanie Gerbig; Bernhard Spengler; Andreas Schwiertz; Gerhard Breves; Martin Diener
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

2.  The role of the immune system in regulating the microbiota.

Authors:  Benjamin P Willing; Navkiran Gill; B Brett Finlay
Journal:  Gut Microbes       Date:  2010-03-04

3.  Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids.

Authors:  A Cait; M R Hughes; F Antignano; J Cait; P A Dimitriu; K R Maas; L A Reynolds; L Hacker; J Mohr; B B Finlay; C Zaph; K M McNagny; W W Mohn
Journal:  Mucosal Immunol       Date:  2017-10-25       Impact factor: 7.313

4.  Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea.

Authors:  Marlene Wullt; Marie-Louise Johansson Hagslätt; Inga Odenholt; Anna Berggren
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

5.  The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity.

Authors:  Yuliia Holota; Taisa Dovbynchuk; Izumi Kaji; Igor Vareniuk; Natalia Dzyubenko; Tetiana Chervinska; Liudmyla Zakordonets; Viktoria Stetska; Liudmyla Ostapchenko; Tetiana Serhiychuk; Ganna Tolstanova
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

6.  Fermentation Characteristics and In Vitro Digestibility of Fibers and Fiber-Rich Byproducts Used for the Feeding of Pigs.

Authors:  Martin Bachmann; Sebastian Michel; Jörg Michael Greef; Annette Zeyner
Journal:  Animals (Basel)       Date:  2021-01-29       Impact factor: 2.752

7.  An in vitro fermentation model to study the impact of bacteriophages targeting Shiga toxin-encoding Escherichia coli on the colonic microbiota.

Authors:  Graça Pinto; Sudarshan A Shetty; Erwin G Zoetendal; Raquel F S Gonçalves; Ana C Pinheiro; Carina Almeida; Joana Azeredo; Hauke Smidt
Journal:  NPJ Biofilms Microbiomes       Date:  2022-09-26       Impact factor: 8.462

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.